• News
  • SAN DIEGO
  • BioTech

Pernix will buy Somaxon Pharma for $25M in stock

Children's medicine maker Pernix Therapeutics Holdings Inc. said Tuesday that it will buy insomnia treatment maker Somaxon Pharmaceuticals Inc. for about $25 million in stock.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!